• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/08/2023
Event Type  malfunction  
Event Description
It was reported that the stent failed to fully expand.The 100% stenosed target lesion was located in the severely calcified and severely tortuous superficial femoral artery (sfa).A 7x80, 130 cm eluvia drug-eluting vascular stent system was selected for use.During stent deployment, the radial force of the stent was not enough to treat the lesion.The procedure was completed with this device.No patient complications were reported and the patient status was good.
 
Event Description
It was reported that the stent failed to fully expand.The 100% stenosed target lesion was located in the severely calcified and severely tortuous superficial femoral artery (sfa).A 7x80, 130 cm eluvia drug-eluting vascular stent system was selected for use.During stent deployment, the radial force of the stent was not enough to treat the lesion.The procedure was completed with this device.No patient complications were reported and the patient status was good.It was further reported that the reference vessel diameter was 5.5mm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16267832
MDR Text Key308575560
Report Number2124215-2023-03640
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/26/2023
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0027223632
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/09/2023
Initial Date FDA Received01/30/2023
Supplement Dates Manufacturer Received05/25/2023
Supplement Dates FDA Received06/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/26/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age81 YR
Patient SexMale
-
-